Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply.
Safadi R, Braun M, Francis A, Milgrom Y, Massarwa M, Hakimian D, Hazou W, Issachar A, Harpaz Z, Farbstein M, Itzhak I, Lev-Cohain N, Bareket-Samish A, Silverman MH, Fishman P.
Safadi R, et al. Among authors: hazou w.
Aliment Pharmacol Ther. 2022 Feb;55(4):485-486. doi: 10.1111/apt.16762.
Aliment Pharmacol Ther. 2022.
PMID: 35092054
No abstract available.